Can a 14-Day pill lift postpartum depression?
NCT ID NCT07096791
First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time
Summary
This trial tests whether an experimental drug called KH607 can reduce symptoms of postpartum depression in adult women. Participants take the drug or a placebo once daily for two weeks. The study measures changes in depression scores to see if KH607 offers a safe and effective short-term treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental drug called KH607 taken as a tablet once daily for 14 days
- What this could lead to
- If effective, KH607 could offer a new, short-course treatment option for postpartum depression.
- What could go wrong
- This is an early phase 2 trial with only 72 participants, so results may not apply broadly. The drug's safety and effectiveness are still unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BeiJing AnDing Hospital capital medical University
Beijing, China